ACCESSION: MSBNK-SMB_Measured-HSA015P0086003
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 22
COMMENT: RAW_SPEC {'EL13_pos_1851': {'bp': 67592.0, 'sum': 370382.0}, 'EL12_pos_1852': {'bp': 66522.0, 'sum': 365506.0}, 'EL02_pos_1852': {'bp': 66281.0, 'sum': 401277.0}, 'EL22_pos_1857': {'bp': 61648.0, 'sum': 361522.0}, 'EL01_pos_1846': {'bp': 59904.0, 'sum': 350822.0}, 'EL08_pos_1846': {'bp': 58967.0, 'sum': 330300.0}, 'EL11_pos_1851': {'bp': 58965.0, 'sum': 339411.0}, 'EL06_pos_1857': {'bp': 58917.0, 'sum': 364170.0}, 'EL23_pos_1852': {'bp': 58357.0, 'sum': 317159.0}, 'EL09_pos_1852': {'bp': 56733.0, 'sum': 330831.0}, 'EL21_pos_1845': {'bp': 55677.0, 'sum': 337306.0}, 'EL15_pos_1851': {'bp': 55330.0, 'sum': 332221.0}, 'EL17_pos_1840': {'bp': 55035.0, 'sum': 344175.0}, 'EL24_pos_1863': {'bp': 55007.0, 'sum': 328248.0}, 'EL14_pos_1851': {'bp': 54501.0, 'sum': 350791.0}, 'EL18_pos_1846': {'bp': 52675.0, 'sum': 342467.0}, 'EL19_pos_1859': {'bp': 52591.0, 'sum': 330156.0}, 'EL05_pos_1852': {'bp': 51450.0, 'sum': 330945.0}, 'EL20_pos_1839': {'bp': 49952.0, 'sum': 317163.0}, 'EL16_pos_1851': {'bp': 49733.0, 'sum': 321145.0}, 'EL10_pos_1845': {'bp': 48392.0, 'sum': 305915.0}, 'EL07_pos_1845': {'bp': 47177.0, 'sum': 316453.0}}
COMMENT: RETENTION_TIME_STDEV 0.007
COMMENT: PRECURSOR_M/Z_RAW 86.097089
COMMENT: PRECURSOR_M/Z_STDEV 0.000030
COMMENT: PRECURSOR_IN_MS1 mz 86.096418; int 24.597; delta(ppm) 0.419623
COMMENT: PROPOSED_CHARGE_STATE +1; mz 87.099785; int 1.469; cor 0.637
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.071; C5H11N; [M+H]+; delta(ppm) -0.070514
COMMENT: PROPOSED_MF MS-FINDER 3.388; C5H11N; [M+H]+; delta(ppm) -0.078867
COMMENT: PROPOSED_MF SIRIUS6_Sirius 0.997; C5H11N; [M+H]+; delta(ppm) -0.078867
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C5H11N; [M+H]+; delta(ppm) -0.078867
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 8.000; NQRYJNQNLNOLGT-UHFFFAOYSA-N; C5H11N; Massbank:PR100190 PiperidineHexahydropyridinePerhydroazinePerhydropyridineAzacyclohexaneCyclopentimineCypentilHexazanePentamethyleneiminePentamethylenimine
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.000; AVFZOVWCLRSYKC-UHFFFAOYSA-N; [M+H]+; CN1CCCC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.690; NQRYJNQNLNOLGT-UHFFFAOYSA-N; [M+H]+; C1CCNCC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.619; NISGSNTVMOOSJQ-UHFFFAOYSA-N; [M+H]+; C1CCC(C1)N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.333; FQIMPUOQPQNHRX-UHFFFAOYSA-N; [M+H]+; N(=CC(C)C)C
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.426; NQRYJNQNLNOLGT-UHFFFAOYSA-N; [M+H]+; Piperidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.787; AVFZOVWCLRSYKC-UHFFFAOYSA-N; [M+H]+; N-Methylpyrrolidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.454; NISGSNTVMOOSJQ-UHFFFAOYSA-N; [M+H]+; cyclopentanamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.245; FQIMPUOQPQNHRX-UHFFFAOYSA-N; [M+H]+; methyl(2-methylpropylidene)amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; NQRYJNQNLNOLGT-UHFFFAOYSA-N; [M+H]+; Piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; AVFZOVWCLRSYKC-UHFFFAOYSA-N; [M+H]+; N-Methylpyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; NISGSNTVMOOSJQ-UHFFFAOYSA-N; [M+H]+; cyclopentanamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; FQIMPUOQPQNHRX-UHFFFAOYSA-N; [M+H]+; methyl(2-methylpropylidene)amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.000; NQRYJNQNLNOLGT-UHFFFAOYSA-N; [M+H]+; piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.213; AVFZOVWCLRSYKC-UHFFFAOYSA-N; [M+H]+; 1-methylpyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.857; NISGSNTVMOOSJQ-UHFFFAOYSA-N; [M+H]+; cyclopentanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.464; RGHPCLZJAFCTIK-UHFFFAOYSA-N; [M+H]+; 2-methylpyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.298; GBCKRQRXNXQQPW-UHFFFAOYSA-N; [M+H]+; N,N-dimethylprop-2-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.251; RSUCYDXEFFBUSN-UHFFFAOYSA-N; [M+H]+; N-tert-butylmethanimine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.154; KYINPWAJIVTFBW-UHFFFAOYSA-N; [M+H]+; 3-methylpyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.143; LQNHRNOPWKZUSN-UHFFFAOYSA-N; [M+H]+; cyclobutylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.143; UVBBCQLPTZEDHT-UHFFFAOYSA-N; [M+H]+; pent-4-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.138; ZOGZOXRETBBBJI-UHFFFAOYSA-N; [M+H]+; 2-cyclopropylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.138; PUUULGNNRPBVBA-UHFFFAOYSA-N; [M+H]+; N-ethylprop-2-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.137; PFCBHFDNVFQUJI-UHFFFAOYSA-N; [M+H]+; 3-methylbut-2-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.137; BFPMCZWKUSUMKE-UHFFFAOYSA-N; [M+H]+; 1-cyclopropyl-N-methylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.136; JSIGUUUNVYUWQT-UHFFFAOYSA-N; [M+H]+; N-methylcyclobutanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.136; IXCXVGWKYIDNOS-UHFFFAOYSA-N; [M+H]+; 1-cyclopropylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.131; ZAXBVBGWLMVNJN-UHFFFAOYSA-N; [M+H]+; 1-methylcyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.131; ULEZWUGQDAQWPT-UHFFFAOYSA-N; [M+H]+; N-ethylcyclopropanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.130; RLVVIGIYIMDCAU-UHFFFAOYSA-N; [M+H]+; 3,3-dimethylazetidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.127; BPIDLOWRIYHHBQ-UHFFFAOYSA-N; [M+H]+; pent-4-en-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.127; NIJMHZCHTZXLJX-UHFFFAOYSA-N; [M+H]+; (1-methylcyclopropyl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.127; NJTBJCGFHPFCQL-UHFFFAOYSA-N; [M+H]+; 3-methylbut-3-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.127; QKWULNOMHKBBLA-UHFFFAOYSA-N; [M+H]+; N-methylbut-3-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.126; RBRPAKDHMRWACJ-UHFFFAOYSA-N; [M+H]+; 2-methylbut-3-en-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.126; IVYCMLREPMLLEO-UHFFFAOYSA-N; [M+H]+; 2,2-dimethylcyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.126; GNHDRVDLNQEOPA-UHFFFAOYSA-N; [M+H]+; 3-methylcyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.126; KYTQSTIMXRWCDS-UHFFFAOYSA-N; [M+H]+; N,1-dimethylcyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.126; KTHMOBNDGBTCLB-UHFFFAOYSA-N; [M+H]+; 2,2-dimethylazetidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.126; NZZNMDNKJVUJAL-UHFFFAOYSA-N; [M+H]+; 2-ethylazetidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.126; NOBVTKCADZWKHR-UHFFFAOYSA-N; [M+H]+; N,2-dimethylprop-2-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.126; BRWRRWXQMCPPRZ-UHFFFAOYSA-N; [M+H]+; (2-methylcyclopropyl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.126; YPIDADKMTAZBST-UHFFFAOYSA-N; [M+H]+; 2,4-dimethylazetidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.126; YYMQZXMSPLVJJN-UHFFFAOYSA-N; [M+H]+; 2-methylcyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.126; GAZWKJNMLLGPKV-UHFFFAOYSA-N; [M+H]+; 2-ethylcyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.125; PMGNVDPARHYFIN-UHFFFAOYSA-N; [M+H]+; N-methylbut-3-en-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.125; BMVHDBKYVGUEIX-UHFFFAOYSA-N; [M+H]+; 2,3-dimethylazetidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.125; FVVGXRJNWIYMNJ-UHFFFAOYSA-N; [M+H]+; 1,2-dimethylcyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.125; VWJYDONMXDIHNY-NSCUHMNNSA-N; [M+H]+; (E)-pent-3-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.125; IAWXHEPLJXAMSG-ONEGZZNKSA-N; [M+H]+; (E)-pent-2-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.125; JHTQHOGTBDMULK-RXMQYKEDSA-N; [M+H]+; (2S)-2-propan-2-ylaziridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.125; RHJITQJBHCWZLJ-RFZPGFLSSA-N; [M+H]+; (1R,2R)-N,2-dimethylcyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.125; FJUWTTDYFTWJLY-QWWZWVQMSA-N; [M+H]+; (2R,3R)-2,3-dimethylcyclopropan-1-amine
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C5H12N1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 2.983
MS$FOCUSED_ION: PRECURSOR_M/Z 86.096419
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-000i-9000000000-1725fdfabf3dc249d37c
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  53.0024513 96.8234 53.003149 0.6981 28.19 0.8143 21 ?
  56.0497455 192.6280 56.050458 0.9456 52.97 -0.0536 22 f{C3H6N1}/4.82ppm,p-C2H6
  56.9650585 300.1005 56.965775 0.5442 44.78 -0.2897 22 ?
  57.0337419 130.8507 57.034458 0.9643 35.38 0.1609 22 ?
  57.0700720 49.9788 57.070788 1.3843 12.65 -0.0045 20 f{C4H9}/3.42ppm,p-C1H3N1
  58.0653665 127.9862 58.066087 0.7578 20.56 0.4342 22 f{C3H8N1}/4.15ppm,p-C2H4
  59.0493638 69.4866 59.050088 0.8298 19.63 -0.4143 21 ?
  67.0543608 107.9697 67.055102 0.9992 19.94 0.2095 22 f{C5H7}/2.00ppm,p-H5N1
  69.0336106 122.0817 69.034354 1.2023 28.38 0.1643 22 ?
  70.0652631 137.1563 70.066006 0.9563 21.63 -0.1711 22 f{C4H8N1}/1.96ppm,p-C1H4
  71.0129129 45.9967 71.013656 1.5349 13.76 -0.0382 18 ?
  71.9519971 156.0353 71.952740 1.2508 22.92 0.0649 21 ?
  84.0444558 469.1224 84.045171 0.4878 124.87 -0.1519 22 ?
  84.0808326 57.1189 84.081548 0.9634 11.84 0.3558 21 f{C5H10N1}/0.68ppm,p-H2
  84.9597473 396.8658 84.960459 0.5414 39.48 0.1971 22 ?
  85.0284658 465.3782 85.029177 0.5057 94.27 0.2637 22 ?
  85.0397186 86.8369 85.040430 1.1406 22.66 0.3078 21 ?
  85.0477923 73.6108 85.048504 1.3051 23.46 0.1404 19 ?
  85.0648619 141.2650 85.065573 0.9992 23.35 0.3089 22 ?
  86.0237275 172.1471 86.024434 0.9881 23.71 0.0593 22 ?
  86.0600909 999.0000 86.060798 0.4299 0.00 0.6318 22 ?
  86.0964589 336.3317 86.097166 0.6156 71.21 1.0000 22 f{C5H12N1}/0.38ppm,p
  87.0440993 380.6299 87.044801 0.7238 54.28 0.4037 22 ?
  87.0553339 93.3603 87.056036 1.0453 18.66 0.0536 22 ?
  87.0917819 117.1235 87.092484 0.9760 33.39 -0.4176 16 ?
  88.0216196 131.2850 88.022317 0.8293 28.34 0.2570 18 ?
  88.0757211 147.9203 88.076418 0.8175 27.62 0.5754 19 ?
PK$NUM_PEAK: 27
PK$PEAK: m/z int. rel.int.
  53.002451 96.82 96
  56.049745 192.63 192
  56.965058 300.10 300
  57.033742 130.85 130
  57.070072 49.98 49
  58.065366 127.99 127
  59.049364 69.49 69
  67.054361 107.97 107
  69.033611 122.08 122
  70.065263 137.16 137
  71.012913 46.00 45
  71.951997 156.04 156
  84.044456 469.12 469
  84.080833 57.12 57
  84.959747 396.87 396
  85.028466 465.38 465
  85.039719 86.84 86
  85.047792 73.61 73
  85.064862 141.26 141
  86.023728 172.15 172
  86.060091 999.00 999
  86.096459 336.33 336
  87.044099 380.63 380
  87.055334 93.36 93
  87.091782 117.12 117
  88.021620 131.28 131
  88.075721 147.92 147
//
